Olanzapine

7 trials 4 recruiting NNeurology/Psychiatry

Filter these 7 trials by condition, phase, country and more.

Open in Search →

7 Registered trials

4 Recruiting

3 Completed trials

6 Sponsors

10 Countries

Phase III

Phase II

Phase IV

Phase III: 2 Phase II: 3 Phase IV: 2

Oversight events:

1 temporary halt 3 urgent safety measures across 1 trial

View oversight register →

Indications tested

Heart valve operation 1 Schizophrenia 1 Papillary serous endometrial carcinoma 1 HER2 positive breast cancer 1

Sponsors using this IMP

Rigshospitalet 2 K-Group Beta Inc. 1 Karolinska University Hospital 1 Karyopharm Therapeutics Inc. 1 Masarykova Univerzita 1 Universitair Medisch Centrum Groningen 1

All trials

7 total

A Randomized Trial of Trastuzumab Deruxtecan and Biology-Driven Selection of Neoadjuvant Treatment for HER2-positive Breast Cancer Recruiting

2022-501504-95-00 Phase II 3 countries Karolinska University Hospital
The Danish Out-of-Hospital Cardiac Arrest study (DANOHCA) Recruiting

2024-515997-28-00 Phase III 1 country Rigshospitalet
Dexamethasone, olanzapine, hemodynamics, and ventilation in cardiac surgery (GLORIOUSII) Recruiting

2024-515998-94-00 Phase III 1 country Rigshospitalet
Selinexor, Dexamethasone and Bortezomib in Patients with Multiple Myeloma Recruiting

2024-511608-18-00 Phase II 1 country Karyopharm Therapeutics Inc.
HAMLETT. Handling Antipsychotic Medication: Long-term Evaluation of Targeted Treatment. A study comparing continuation versus discontinuatio… Ended

2024-518769-80-00 Phase IV 1 country Universitair Medisch Centrum Groningen
A Study of ZN-c3 in Women With Recurrent or Persistent Uterine Serous Carcinoma Ended

2023-507324-23-00 Phase II 3 countries K-Group Beta Inc.
Safety and efficacy of olanzapine treatment in psychosis: Effect of genetic and epigenetic factors – covariates of treatment response Ended

2022-502902-33-00 Phase IV 1 country Masarykova Univerzita

Showing 1–7 of 7 trials

← All drugs A–Z